Introduction

This page provides a comprehensive analysis of the known insider trading history of Richard H Booth. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Richard H Booth has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:THG / The Hanover Insurance Group, Inc. Director 2,043
US:ADMS / Adamas Pharmaceuticals Inc Director 15,000
BR:E1SE34 / Eversource Energy - Depositary Receipt (Common Stock) 50,398
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Richard H Booth. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Trading History

This table shows the complete list of insider trades made by Richard H Booth as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2018-01-29 2018-01-02 4 THG HANOVER INSURANCE GROUP, INC.
Common Stock
J - Other 1,543 2,043 308.60
2018-01-29 2018-01-02 4 THG HANOVER INSURANCE GROUP, INC.
Common Stock
J - Other -1,543 6,344 -19.56
2017-06-02 2017-06-01 4 ADMS Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
A - Award 15,000 15,000
2017-05-17 2017-05-16 4 THG HANOVER INSURANCE GROUP, INC.
Common Stock
A - Award 1,543 7,887 24.32
2016-06-07 2016-06-03 4 ADMS Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
A - Award 15,000 15,000
2016-05-26 2016-05-24 4 THG HANOVER INSURANCE GROUP, INC.
Common Stock
A - Award 1,435 6,344 29.23
2015-06-17 2015-06-15 4 ADMS Adamas Pharmaceuticals Inc
Common Stock
S - Sale -1,000 45,778 -2.14 19.32 -19,320 884,431
2015-05-21 2015-05-19 4 THG HANOVER INSURANCE GROUP, INC.
Common Stock
A - Award 1,751 4,909 55.45
2015-05-18 2015-05-15 4 ADMS Adamas Pharmaceuticals Inc
Common Stock
S - Sale -1,000 46,778 -2.09 17.85 -17,850 834,987
2015-05-18 2015-05-14 4 ADMS Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
A - Award 19,000 19,000
2015-04-16 2015-04-15 4 ADMS Adamas Pharmaceuticals Inc
Common Stock
S - Sale -1,000 47,778 -2.05 17.72 -17,720 846,626
2015-03-17 2015-03-16 4 ADMS Adamas Pharmaceuticals Inc
Common Stock
S - Sale -1,000 48,778 -2.01 17.36 -17,360 846,786
2015-02-18 2015-02-17 4 ADMS Adamas Pharmaceuticals Inc
Common Stock
S - Sale -1,000 49,778 -1.97 16.54 -16,540 823,328
2015-01-20 2015-01-15 4 NU NORTHEAST UTILITIES
Common Shares, $5.00 par value
A - Award 1,863 50,398 3.84
2015-01-20 2015-01-15 4 ADMS Adamas Pharmaceuticals Inc
Common Stock
S - Sale -1,000 50,778 -1.93 17.43 -17,430 885,061
2014-12-29 2014-12-24 4 ADMS Adamas Pharmaceuticals Inc
Common Stock
S - Sale -2,000 51,778 -3.72 17.51 -35,020 906,633
2014-09-09 2014-09-05 4 ADMS Adamas Pharmaceuticals Inc
Common Stock Warrant
X - Other -17,778 0 -100.00
2014-09-09 2014-09-05 4 ADMS Adamas Pharmaceuticals Inc
Common Stock
X - Other 17,778 53,778 49.38 4.50 80,001 242,001
2014-05-22 2014-05-20 4 THG HANOVER INSURANCE GROUP, INC.
Common Stock
A - Award 1,930 3,158 157.17
2014-04-09 3 ADMS Adamas Pharmaceuticals Inc
Common Stock
72,000
2014-04-09 3 ADMS Adamas Pharmaceuticals Inc
Common Stock
72,000
2014-02-25 2014-02-25 4 THG HANOVER INSURANCE GROUP, INC.
Common Stock
P - Purchase 500 500 58.19 29,096 29,096
2014-01-17 2014-01-15 4 NU NORTHEAST UTILITIES
Common Shares, $5.00 par value
A - Award 2,381 46,992 5.34
2013-10-15 2013-10-10 4 THG HANOVER INSURANCE GROUP, INC.
Common Stock
A - Award 1,228 1,228
2013-10-15 3 THG HANOVER INSURANCE GROUP, INC.
Common Stock
0
2013-01-17 2013-01-15 4 NU NORTHEAST UTILITIES
Common Shares, $5.00 par value
A - Award 2,545 43,126 6.27
2012-04-04 2012-04-02 4 NU NORTHEAST UTILITIES
Common Shares, $5.00 par value
A - Award 67 39,547 0.17 37.11 2,486 1,467,589
2012-01-05 2012-01-03 4 NU NORTHEAST UTILITIES
Common Shares, $5.00 par value
A - Award 3,000 39,178 8.29
2012-01-05 2012-01-03 4 NU NORTHEAST UTILITIES
Common Shares, $5.00 par value
A - Award 68 36,178 0.19 36.44 2,478 1,318,326
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)